penadur 1.2m.i.u.vial
egyptian pharmaceutical trading company - injection - 1.2 m.i.u.
penadur la
wyeth (nz) ltd - benzathine benzylpenicillin 1.2 miu - injection with diluent - 1.2 miu - active: benzathine benzylpenicillin 1.2 miu excipient: water for injection
penadur la
wyeth (nz) ltd - benzathine benzylpenicillin 600000 [iu] - injection with diluent - 600000 iu - active: benzathine benzylpenicillin 600000 [iu] excipient: water for injection
mepivacaine hcl 3 % injection
henry schein shvadent (2009 ) ltd - mepivacaine hydrochloride - solution for injection - mepivacaine hydrochloride 30 mg/ml - mepivacaine - mepivacaine - mepivacaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients.
nimenrix powder and solvent for solution for injection
pfizer private limited - neisseria meningitidis group a polysaccharide; neisseria meningitidis group c polysaccharide; neisseria meningitidis group w-135 polysaccharide; neisseria meningitidis group y polysaccharide; tetanus toxoid carrier protein - injection, powder, for solution - 5 micrograms - neisseria meningitidis group a polysaccharide 5 micrograms; neisseria meningitidis group c polysaccharide 5 micrograms; neisseria meningitidis group w-135 polysaccharide 5 micrograms; neisseria meningitidis group y polysaccharide 5 micrograms; tetanus toxoid carrier protein ~44 micrograms
synagis sterile powder for injection 100 mgvial
abbvie pte. ltd. - palivizumab - injection, powder, for solution - 100 mg/vial (100mg/ml) - palivizumab 100 mg/vial (100mg/ml)
adacel® suspension for injection
sanofi-aventis singapore pte. ltd. - (acellular pertussis) filamentous haemagglutinin adsorbed (fha); (acellular pertussis) fimbriae type 2 and 3 adsorbed (fim); (acellular pertussis) pertactin adsorbed (prn); (acelullar pertussis) pertussis toxoid adsorbed (pt); diphtheria toxoid adsorbed; tetanus toxoid adsorbed - injection, suspension - 5 micrograms - (acellular pertussis) filamentous haemagglutinin adsorbed (fha) 5 micrograms; (acellular pertussis) fimbriae type 2 and 3 adsorbed (fim) 5 micrograms; (acellular pertussis) pertactin adsorbed (prn) 3 micrograms; (acelullar pertussis) pertussis toxoid adsorbed (pt) 2.5 micrograms; diphtheria toxoid adsorbed 2 lf; tetanus toxoid adsorbed 5 lf
oraverse- phentolamine mesylate injection, solution for submucosal use
novalar pharmaceuticals - phentolamine mesylate (unii: y7543e5k9t) (phentolamine - unii:z468598hbv) - injection, solution - 0.4 mg in 1.7 ml - oraverse is indicated for reversal of the soft-tissue anesthesia, i.e., anesthesia of the lip and tongue, and the associated functional deficits resulting from an intraoral submucosal injection of a local anesthetic containing a vasoconstrictor. oraverse is not recommended for use in children less than 6 years of age or weighing less than 15 kg (33 lbs). none. pregnancy category c there are no adequate and well-controlled studies in pregnant women. oraverse should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral administration of phentolamine to pregnant rats and mice at doses at least 24 times the recommended dose (based on a 60 kg human) resulted in slightly decreased growth and slight skeletal immaturity of the fetuses. immaturity was manifested by increased incidence of incomplete or unossified calcaneal and phalangeal nuclei of the hind limb and of incompletely ossified sternebrae. at oral phentolamine doses at least 60 times the recommended dose (ba
octocaine 100 injection
n.k. luck (s) pte ltd - epinephrine bitartrate 0.018mg/ml eqv epinephrine; lidocaine hcl monohydrate 21.34mg/ml eqv lidocaine hcl - injection - epinephrine bitartrate 0.018mg/ml eqv epinephrine 0.01mg/ml; lidocaine hcl monohydrate 21.34mg/ml eqv lidocaine hcl 20mg/ml
spikevax 0.1 mgml dispersion for injection
moderna biotech singapore pte. ltd. - andusomeran - injection, solution - andusomeran 0.10 mg/ml